Page semi-protected

Ariel Fernandez

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Ariel Fernandez
Dr. Ariel Fernandez, 2016.jpg
Born (1957-04-08) April 8, 1957 (age 64)
Citizenship
  • Argentina
  • USA
Alma mater
Known forDehydrons
Scientific career
Fields
Institutions
ThesisStructural Stability of Chemical Systems at Critical Regimes (1984)
Doctoral advisorOktay Sinanoğlu
Websitewww.profarielfernandez.com

Ariel Fernandez (born Ariel Fernández Stigliano, April 8, 1957) is an ArgentinianAmerican physical chemist and pharmaceutical researcher.[1]

Education and early career

Fernandez received Licentiate degrees in Chemistry (1979) and Mathematics (1980) from the Universidad Nacional del Sur, Argentina.[1] He then earned a Ph.D. from Yale University in 1984 with a thesis entitled Structural Stability of Chemical Systems at Critical Regimes[2][1]

Career

Fernandez held the Karl F. Hasselmann Professorship of Bioengineering at Rice University until 2011.[3] He is a member of the National Scientific and Technical Research Council (CONICET) in Argentina.[4]

Fernandez developed the concept of the dehydron, an adhesive structural defect in a soluble protein that promotes its own dehydration.[5] The nonconserved nature of protein dehydrons has implications for drug discovery, as dehydrons may be targeted by highly specific drugs/ligands.[6] This technology was applied by Fernandez and collaborators to design a new compound based on the anticancer drug Gleevec, in order to remove its potential cardiotoxicity.[7][8]

Awards

Fernandez was awarded the Camille and Henry Dreyfus Dreyfus Teacher-Scholar in 1991;[9] a Guggenheim fellowship in 1995;[10] and was an Elected Fellow of the American Institute for Medical and Biological Engineering (2006).[11]

Published books

  • Transformative Concepts for Drug Design: Target Wrapping, by Ariel Fernández (ISBN 978-3642117916, Springer-Verlag, Berlin, Heidelberg, 2010).
  • Biomolecular Interfaces, by Ariel Fernández Stigliano (ISBN 978-3319168494, Springer-Verlag, Berlin, Heidelberg, 2015).
  • Physics at the Biomolecular Interface, by Ariel Fernández (ISBN 978-3319308517, Springer International Publishing AG, Switzerland, 2016).
  • A Mathematical Approach to Protein Biophysics, by L. Ridgeway Scott and Ariel Fernández (ISBN 978-3319660318, Springer, 2017).
  • Artificial Intelligence Platform for Molecular Targeted Therapy: A Translational Science Approach, by Ariel Fernández (ISBN 978-9811232305, World Scientific Publishing Co., 2021).

References

  1. ^ a b c Ariel Fernandez. "Ariel Fernandez CV and Biographical Narrative". Academia.edu.
  2. ^ Ariel Fernandez. Yale University Dissertation: Structural Stability of Chemical Systems at Critical Regimes (Dissipative Structures, Potential Energy Surfaces). Published/Created:1984
  3. ^ "Administration and faculty", Catalog 2010–2011, Rice University, archived from the original (PDF) on November 25, 2014, retrieved December 2, 2014.
  4. ^ "Comunicación - Conicet". CONICET.
  5. ^ Monroe, Dan (2012). "Proteins Hook up Where Water Allows". Physics. 5 (51): 51. Bibcode:2012PhyOJ...5...51M. doi:10.1103/Physics.5.51. Retrieved June 23, 2021.
  6. ^ Crunkhorn, Sarah (2008). "Anticancer drugs: Redesigning kinase inhibitors". Nature Reviews Drug Discovery. 7: 120–121. doi:10.1038/nrd2524. S2CID 27083179.
  7. ^ Demetri G. D. Structural reengineering of imatinib to decrease cardiac risk in cancer therapy.2007 Dec 3; J Clin Invest. 117(12):3650–3653. doi 10.1172/JCI34252 [1]
  8. ^ Dunham W. Reworked Gleevec curbs heart-related complication. REUTERS December 3, 2007 [2]
  9. ^ "Camille Dreyfus Teacher-Scholar Awards Program Past Awards" (PDF). Archived from the original (PDF) on July 5, 2016. Retrieved December 3, 2014.
  10. ^ "Ariel Fernández". Fellows. John Simon Guggenheim Memorial Foundation. Retrieved September 27, 2012.
  11. ^ "College of Fellows". Members. American Institute for Medical and Biological Engineering. Retrieved September 27, 2012.